FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Difluprednate

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot # DEG3LC2, Exp 05/2023
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Lack of Assurance of Sterility: Complaints received of defective container closure.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byCipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059 foreign manufacturer
Brand nameDIFLUPREDNATE
Generic nameDIFLUPREDNATE
Active ingredient(s)DIFLUPREDNATE
Distributed by / forCipla USA, Inc., NJ 07059
NDC69097-341-35
Show the full FDA record
Full product labelDifluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.
Recalling firmCIPLA
DistributionNationwide in the USA
Quantity7,992 bottles
Recall initiated2022-08-02
Report date2022-08-17
Recall completed2023-11-27
Recall numberD-1328-2022
ClassificationClass II
FDA statusTerminated
Origin on fileWarren NJ United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.